This consultation is aimed at professionals in the pharmaceutical industry and in medicine who know what they're talking about.
I'm neither of those but I'm not scared of detail so I had a nose the other day after a similar thread was started. The legal framework already exists for unlicenced medicines to be distributed in certain conditions of public health threat.
The proposal is that these regulations are amended to make clear that conditions can be attached to this type of temporary authorisation:
To provide transparency, we propose to amend the HMRs to make it explicit that the supply of products, including COVID-19 vaccines, which is temporarily authorised under regulation 174 may be subject to conditions. The imposition of conditions enables the licensing authority to define the safeguards that are a pre-requisite for the safe supply and use of the product and without which authorisation would not be valid. This can range from specifying whom the product is suitable for, setting batch testing and quality assurance standards, and ensuring that appropriate storage is in place throughout the supply chain. Given its importance, it is appropriate to articulate this element of the licensing authority’s decision-making more fully in the legislation.
It will be the government who decides that a certain vaccine can be given a temporary authorisation, not the pharmaceutical companies or manufacturers. It's therefore only fair that the buck stops with the government. Why on earth would they agree to supply the UK with such a massive legal threat hanging over them if anything went wrong? It's not like they lack other markets around the world ...
To be clear, before any vaccine gets temporary authorisation while waiting to be licensed it will already have been through all the necessary trials to ensure it is safe and effective.